Rami S. Komrokji
Moffitt Cancer Center(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Hemoglobinopathies and Related Disorders
Most-Cited Works
- → Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes(2020)527 cited
- → Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes(2021)441 cited
- → The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype(2016)341 cited
- → Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML(2014)334 cited
- → A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis(2017)325 cited
- → Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study(2016)308 cited
- → Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology(2016)293 cited
- → SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS(2020)289 cited
- → Myelodysplastic Syndromes(2011)289 cited
- → Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)(2021)261 cited